Clinical Trial Update: Calcitriol Monotherapy for X-Linked Hypophosphatemia [EARLY_Phase 1]

View source ↗

Summary

The document reports an EARLY_PHASE1 trial of Calcitriol as monotherapy for X-linked hypophosphatemia with status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatemic Rickets
• Hypophosphatemic Rickets X-linked Dominant
• X-linked Hypophosphatemia

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: X-linked Hypophosphatemia, Hypophosphatemic Rickets | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING